Complications suggested to result from use of a popular anti-nausea medication have been alleged by a number of women who took the drug during their first trimester of pregnancy. These individuals are likely hoping for a Zofran settlement in the future that may result after they file lawsuits against its manufacturer, GlaxoSmithKline. These cases will likely allege serious heart and kidney defects, as well as cleft lips, palates and other issues born to their children, who have had to undergo multiple surgeries to become healthy.
The attorneys at Bernstein Liebhard LLP are committed to helping you file a lawsuit that may eventually result in a Zofran settlement, if the litigation grows large enough. Our Firm is optimistic that this will happen, and you will receive compensation for the out-of-pocket medical bills, lost wages, pain and suffering and other damages you and your family might have sustained as a result of Zofran (Ondansetron) or Zuplenz.
Whether a Zofran settlement occurs in the future likely depends on several factors, including the severity of complications allegedly sustained by the plaintiff, and how many claims are filed against GlaxoSmithKline. Court documents indicate that a number of individuals have already filed claims involving the medication, and a number of studies have explored the possible association between Zofran and serious birth defects.
The most recent was published in a December 2014 issue of the medical journal Clinical Pharmacology & Therapeutics, and was led by researchers who examined blood samples from the umbilical cord of pregnant women, and in the bodies of newborns. The research suggested that Zofran passes the placenta in many cases, meaning that infants can feel the drug’s effects. Before that, a study published in August 2013 at a meeting of the International Society of Pharmacoepidemiology lent evidence to the risk of cardiovascular problems in babies born to mothers who took Zofran. 4.7 percent of these children with born with congenital abnormalities, as opposed to 3.5 percent who had similar issues but weren’t exposed to the drug. Presenters concluded that women taking Zofran were 30 percent more likely to have a baby with birth defects.
Individuals who allege one or more of the following complications may be eligible to file a Zofran lawsuit that may result in a large settlement if sufficient evidence proves that they were caused by the anti-nausea medication. Certain defects may occur if the mother took Zofran for morning sickness during her first trimester of pregnancy.
Attorneys at Bernstein Liebhard LLP are standing by to answer any questions you have regarding the legal process of filing a zofran lawsuit that could be resolved through a Zofran settlement by GlaxoSmithKline. Call the following number to speak with the Firm directly: .